ICC

Icecure Medical

Stock
Stock
ISIN: IL0011224156
Ticker: ICCM
IL0011224156
ICCM

Price

Price

Frequently asked questions

What is Icecure Medical's market capitalization?

The market capitalization of Icecure Medical is $35.27M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Icecure Medical?

Icecure Medical's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.293. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Icecure Medical's stock?

Currently, 4 analysts cover Icecure Medical's stock, with a consensus target price of $3.328. Analyst ratings provide insights into the stock's expected performance.

What is Icecure Medical's revenue over the trailing twelve months?

Over the trailing twelve months, Icecure Medical reported a revenue of $3.34M.

What is the EBITDA for Icecure Medical?

Icecure Medical's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$14.08M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Icecure Medical?

Icecure Medical has a free cash flow of -$11.02M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Icecure Medical's stock?

The 5-year beta for Icecure Medical is 2.53. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Icecure Medical have, and what sector and industry does it belong to?

Icecure Medical employs approximately 71 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of Icecure Medical's shares?

The free float of Icecure Medical is 22.69M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$35.27M

5Y beta

 
2.53

EPS (TTM)

 
-$0.293

Free Float

 
22.69M

Revenue (TTM)

 
$3.34M

EBITDA (TTM)

 
-$14.08M

Free Cashflow (TTM)

 
-$11.02M

Pricing

52W span
$0.48$1.57

Analyst Ratings

The price target is $3.328 and the stock is covered by 4 analysts.

Buy

4

Hold

0

Sell

0

Information

Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.

71

Medical Equipment & Supplies

Health Care

Identifier

ISIN

IL0011224156

Primary Ticker

ICCM
Join the conversation